
Alkaptonuria (AKU) is an ultra-rare condition that’s characterized...
Alkaptonuria (AKU) is an ultra-rare condition that’s characterized...
For the past three years, the life sciences industry has endured challenging circumstances.&...
For a week in June, Meet was lucky to host fifteen-year-old Bethany Pugh (niece of our ...
Cycle Pharmaceuticals: The Company Behind the First FDA-Approved Drug for Alkaptonuria
Read MoreLife Sciences Talent Trends: 5 Key Takeaways from the First Half of 2025
Read MoreBeth Pugh’s Work Experience at Meet Life Sciences
Read MoreTalent Spotlight: Chloe’s Journey at Meet Life Sciences
Read MoreMeet Ranks 50th in SIA’s Fastest-Growing US Staffing Firms List
Read MoreSarcoma Treatments: Recent Advancements in one of the Rarest and ‘Loneliest’ Cancer Forms
Read MoreThe Meet Passport: Shannon & Brocke’s Trip to London
Read MoreMeet Life Sciences Launches Mx: A Standalone Executive Search Brand for the Life Sciences Industry
Read MoreArcellx: The Company Making Exciting Progress for Patients with Relapsed or Refractory Multiple Myeloma
Read More